Advertisement

Topics

TRANSCEND trial data of novel CAR T cell therapy presented

06:21 EDT 19 Jun 2017 | ecancermedicalscience

Data from the TRANSCEND trial of JCAR017 in relapsed and refractory aggressive B cell non-Hodgkin lymphoma (NHL) was presented on June 17th at the 2017 International Conference on Malignant Lymphoma in Lugano, Switzerland. Trial summary notes...

Original Article: TRANSCEND trial data of novel CAR T cell therapy presented

NEXT ARTICLE

More From BioPortfolio on "TRANSCEND trial data of novel CAR T cell therapy presented"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Hodgkin lymphoma
Hodgkin Lymphoma is a  disorder caused by malignant proliferation of lymphocytes, which contain characteristic mirror-image nuclei (Reed-Sternburg cells). The resulting lymphadenopathy can be limited to a single lymph node region (Stage 1) or spread...